{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:16:58Z","timestamp":1791433018118,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99845-5","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:49:39Z","timestamp":1754401779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of metabolomic changes in diagnosis and assessment of treatment response in acute myeloid leukemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Shabbir","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhat","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ikram","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahat Abdul","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausar","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asif","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"3","key":"99845_CR1","first-page":"38","volume":"103","author":"A Pelcovits","year":"2020","unstructured":"Pelcovits, A. & Niroula, R. Acute myeloid leukemia: a review. Rhode Island Med. J. 103 (3), 38\u201340 (2020).","journal-title":"Rhode Island Med. J."},{"key":"99845_CR2","unstructured":"Pelcovits, A. & Niroula, R. J. R. I. Acute myeloid leukemia: a review. 103 (3), 38\u201340 (2020)."},{"key":"99845_CR3","doi-asserted-by":"crossref","unstructured":"Narayanan, D. & Weinberg, O. K. J. I. How I investigate acute myeloid leukemia. 42 (1), 3\u201315 (2020).","DOI":"10.1111\/ijlh.13135"},{"key":"99845_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11010-013-1754-z","volume":"383","author":"Z Wang","year":"2013","unstructured":"Wang, Z., Hong, Z., Gao, F. & Feng, W. J. M. Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia. Biochem. C. 383, 59\u201365 (2013).","journal-title":"Biochem. C"},{"issue":"7","key":"99845_CR5","first-page":"29","volume":"7","author":"EI Obeagu","year":"2021","unstructured":"Obeagu, E. I. & Babar, Q. Acute myeloid leukaemia (AML): the good, the bad, and the ugly. Int. J. Curr. Res. Med. Sci. 7 (7), 29\u201341 (2021).","journal-title":"Int. J. Curr. Res. Med. Sci."},{"issue":"1","key":"99845_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/cells8010076","volume":"8","author":"A Mendes","year":"2019","unstructured":"Mendes, A. & Fahrenkrog, B. NUP214 in leukemia: it\u2019s more than transport. Cells. 8 (1), 76 (2019).","journal-title":"Cells"},{"issue":"1","key":"99845_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000446117","volume":"91","author":"B Gupta","year":"2016","unstructured":"Gupta, B., Johnson, N. W. & Kumar, N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 91 (1), 13\u201323 (2016).","journal-title":"Oncology"},{"issue":"1","key":"99845_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1182\/bloodadvances.2020002981","volume":"5","author":"C Lo Presti","year":"2021","unstructured":"Lo Presti, C., Fauvelle, F., Jacob, M-C., Mondet, J. & Mossuz, P. The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker. Blood Adv. 5 (1), 156\u2013166 (2021).","journal-title":"Blood Adv."},{"key":"99845_CR9","doi-asserted-by":"crossref","unstructured":"Morad, H. M., Abou-Elzahab, M. M., Aref, S. & El-Sokkary, A. M. J. A. Diagnostic value of 1H NMR-based metabolomics in acute lymphoblastic leukemia, acute myeloid leukemia, and breast cancer. 7 (9), 8128\u20138140 (2022).","DOI":"10.1021\/acsomega.2c00083"},{"issue":"1","key":"99845_CR10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/16078454.2020.1781500","volume":"25","author":"H Shen","year":"2020","unstructured":"Shen, H. et al. The diagnostic and prognostic value of MRI in central nervous system involvement of acute myeloid leukemia: a retrospective cohort of 84 patients. Hematology. 25 (1), 258\u2013263 (2020).","journal-title":"Hematology"},{"key":"99845_CR11","doi-asserted-by":"crossref","unstructured":"Wishart, D. S. et al. NMR and metabolomics\u2014A roadmap for the future. 12 (8), 678 (2022).","DOI":"10.3390\/metabo12080678"},{"issue":"1","key":"99845_CR12","doi-asserted-by":"publisher","first-page":"152119","DOI":"10.1016\/j.acthis.2023.152119","volume":"126","author":"S Bharti","year":"2024","unstructured":"Bharti, S. & Kumar, A. Synergies in stem cell research: integrating technologies, strategies, and bionanomaterial innovations. Acta Histochem. 126 (1), 152119 (2024).","journal-title":"Acta Histochem."},{"issue":"9","key":"99845_CR13","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.1021\/acsomega.2c00083","volume":"7","author":"HM Morad","year":"2022","unstructured":"Morad, H. M., Abou-Elzahab, M. M., Aref, S. & El-Sokkary, A. M. Diagnostic value of 1H NMR-based metabolomics in acute lymphoblastic leukemia, acute myeloid leukemia, and breast cancer. ACS Omega. 7 (9), 8128\u20138140 (2022).","journal-title":"ACS Omega"},{"issue":"6","key":"99845_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nprot.2010.45","volume":"5","author":"O Beckonert","year":"2010","unstructured":"Beckonert, O. et al. High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat. Protoc. 5 (6), 1019\u20131032 (2010).","journal-title":"Nat. Protoc."},{"issue":"11","key":"99845_CR15","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1021\/pr200800w","volume":"10","author":"BS Somashekar","year":"2011","unstructured":"Somashekar, B. S. et al. Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J. Proteome Res. 10 (11), 5232\u20135241 (2011).","journal-title":"J. Proteome Res."},{"issue":"4","key":"99845_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1515\/cclm-2018-0380","volume":"57","author":"Z Song","year":"2019","unstructured":"Song, Z., Wang, H., Yin, X., Deng, P. & Jiang, W. Application of NMR metabolomics to search for human disease biomarkers in blood. Clin. Chem. Lab. Med. (CCLM). 57 (4), 417\u2013441 (2019).","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"7","key":"99845_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/pharmaceutics12070646","volume":"12","author":"P Kumar Kulabhusan","year":"2020","unstructured":"Kumar Kulabhusan, P., Hussain, B. & Y\u00fcce, M. Current perspectives on aptamers as diagnostic tools and therapeutic agents. Pharmaceutics 12 (7), 646 (2020).","journal-title":"Pharmaceutics"},{"issue":"10","key":"99845_CR18","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1021\/pr400403p","volume":"12","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Rapid diagnosis and prognosis of de Novo acute myeloid leukemia by serum metabonomic analysis. J. Proteome Res. 12 (10), 4393\u20134401 (2013).","journal-title":"J. Proteome Res."},{"issue":"3","key":"99845_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0360-3016(01)01513-9","volume":"50","author":"Y Chan","year":"2001","unstructured":"Chan, Y. et al. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis. Int. J. Radiat. Oncol. Biol. Phys. 50 (3), 759\u2013763 (2001).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"99845_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1515\/cclm-2019-0130","volume":"58","author":"B Misra","year":"2020","unstructured":"Misra, B. Individualized metabolomics: opportunities and challenges. Clin. Chem. Lab. Med. 58 (6), 939\u2013947. https:\/\/doi.org\/10.1515\/cclm-2019-0130 (2020).","journal-title":"Clin. Chem. Lab. Med."},{"key":"99845_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbacli.2017.03.002","volume":"7","author":"T Pabst","year":"2017","unstructured":"Pabst, T. et al. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA Clin. 7, 105\u2013114 (2017).","journal-title":"BBA Clin."},{"issue":"3","key":"99845_CR22","first-page":"e981988","volume":"2","author":"Y-H Wang","year":"2015","unstructured":"Wang, Y-H. & Scadden, D. T. Targeting the Warburg effect for leukemia therapy: magnitude matters. Mol. Cell. Oncol. 2 (3), e981988 (2015).","journal-title":"Mol. Cell. Oncol."},{"issue":"1","key":"99845_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"H-R Jin","year":"2023","unstructured":"Jin, H-R. et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J. Hematol. Oncol. 16 (1), 103 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"99845_CR24","doi-asserted-by":"publisher","first-page":"924567","DOI":"10.3389\/fonc.2022.924567","volume":"12","author":"RS Maynard","year":"2022","unstructured":"Maynard, R. S., Hellmich, C., Bowles, K. M. & Rushworth, S. A. Acute myeloid leukaemia drives metabolic changes in the bone marrow niche. Front. Oncol. 12, 924567 (2022).","journal-title":"Front. Oncol."},{"issue":"2","key":"99845_CR25","first-page":"85","volume":"135","author":"CD DiNardo","year":"2020","unstructured":"DiNardo, C. D. & Wei, A. H. How I treat acute myeloid leukemia in the era of new drugs. Blood. J. Am. Soc. Hematol. 135 (2), 85\u201396 (2020).","journal-title":"J. Am. Soc. Hematol."},{"issue":"7","key":"99845_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","volume":"159","author":"SA Comerford","year":"2014","unstructured":"Comerford, S. A. et al. Acetate dependence of tumors. Cell 159 (7), 1591\u20131602 (2014).","journal-title":"Cell"},{"issue":"1","key":"99845_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metabol. 23 (1), 27\u201347 (2016).","journal-title":"Cell Metabol."},{"issue":"12","key":"99845_CR28","doi-asserted-by":"publisher","first-page":"e82859","DOI":"10.1371\/journal.pone.0082859","volume":"8","author":"S Tiziani","year":"2013","unstructured":"Tiziani, S. et al. Metabolomics of the tumor microenvironment in pediatric acute lymphoblastic leukemia. PLoS One. 8 (12), e82859 (2013).","journal-title":"PLoS One"},{"issue":"10","key":"99845_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer. 16 (10), 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"99845_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12288-019-01107-8","volume":"35","author":"T Liu","year":"2019","unstructured":"Liu, T., Peng, X-C. & Li, B. The metabolic profiles in hematological malignancies. Indian J. Hematol. Blood Transfus. 35 (4), 625\u2013634 (2019).","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"99845_CR31","doi-asserted-by":"publisher","first-page":"1235160","DOI":"10.3389\/fmolb.2023.1235160","volume":"10","author":"C Ar\u00e9valo","year":"2023","unstructured":"Ar\u00e9valo, C. et al. Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients. Front. Mol. Biosci. 10, 1235160 (2023).","journal-title":"Front. Mol. Biosci."},{"issue":"14","key":"99845_CR32","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1182\/bloodadvances.2022008242","volume":"7","author":"Y Kikushige","year":"2023","unstructured":"Kikushige, Y. et al. Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function. Blood Adv. 7 (14), 3592\u20133603 (2023).","journal-title":"Blood Adv."},{"key":"99845_CR33","doi-asserted-by":"publisher","first-page":"674720","DOI":"10.3389\/fonc.2021.674720","volume":"11","author":"L Fultang","year":"2021","unstructured":"Fultang, L., Gneo, L., De Santo, C. & Mussai, F. J. Targeting amino acid metabolic vulnerabilities in myeloid malignancies. Front. Oncol. 11, 674720 (2021).","journal-title":"Front. Oncol."},{"issue":"5","key":"99845_CR34","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1053\/j.gastro.2018.07.033","volume":"155","author":"R Katagiri","year":"2018","unstructured":"Katagiri, R. et al. Increased levels of branched-chain amino acid associated with increased risk of pancreatic cancer in a prospective case\u2013control study of a large cohort. Gastroenterology 155 (5), 1474\u20131482 (2018). e1471.","journal-title":"Gastroenterology"},{"issue":"9","key":"99845_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/cells8090967","volume":"8","author":"I Castro","year":"2019","unstructured":"Castro, I., Sampaio-Marques, B. & Ludovico, P. Targeting metabolic reprogramming in acute myeloid leukemia. Cells 8 (9), 967 (2019).","journal-title":"Cells"},{"issue":"5930","key":"99845_CR36","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (5930), 1029\u20131033 (2009).","journal-title":"Science"},{"issue":"8","key":"99845_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3390\/cells8080805","volume":"8","author":"J Kreitz","year":"2019","unstructured":"Kreitz, J. et al. Metabolic plasticity of acute myeloid leukemia. Cells 8 (8), 805 (2019).","journal-title":"Cells"},{"issue":"4","key":"99845_CR38","first-page":"389","volume":"134","author":"CL Jones","year":"2019","unstructured":"Jones, C. L. et al. Cysteine depletion targets leukemia stem cells through Inhibition of electron transport complex II. Blood J. Am. Soc. Hematol. 134 (4), 389\u2013394 (2019).","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"6","key":"99845_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3390\/biomedicines10061359","volume":"10","author":"V Raimondi","year":"2022","unstructured":"Raimondi, V., Ciotti, G., Gottardi, M. & Ciccarese, F. 2-hydroxyglutarate in acute myeloid leukemia: a journey from pathogenesis to therapies. Biomedicines 10 (6), 1359 (2022).","journal-title":"Biomedicines"},{"issue":"3","key":"99845_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","volume":"4","author":"R Pan","year":"2014","unstructured":"Pan, R. et al. Selective BCL-2 Inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia. Cancer Discov. 4 (3), 362\u2013375 (2014).","journal-title":"Cancer Discov."},{"issue":"8","key":"99845_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41574-020-0365-5","volume":"16","author":"L Kazak","year":"2020","unstructured":"Kazak, L. & Cohen, P. Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat. Reviews Endocrinol. 16 (8), 421\u2013436 (2020).","journal-title":"Nat. Reviews Endocrinol."},{"key":"99845_CR42","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00726-011-0877-3","volume":"40","author":"T Wallimann","year":"2011","unstructured":"Wallimann, T., Tokarska-Schlattner, M. & Schlattner, U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids. 40, 1271\u20131296 (2011).","journal-title":"Amino Acids"},{"key":"99845_CR43","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00726-011-0974-3","volume":"42","author":"S Patra","year":"2012","unstructured":"Patra, S. et al. A short review on creatine\u2013creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy. Amino Acids. 42, 2319\u20132330 (2012).","journal-title":"Amino Acids"},{"key":"99845_CR44","unstructured":"Gr\u00f8nnings\u00e6ter, I. S. Therapeutic and prognostic implications of metabolism in acute myeloid leukemia. (2020)."},{"issue":"1","key":"99845_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-cancerbio-030419-033556","volume":"4","author":"SK Parks","year":"2020","unstructured":"Parks, S. K., Mueller-Klieser, W. & Pouyss\u00e9gur, J. Lactate and acidity in the cancer microenvironment. Annu. Rev. Cancer Biol. 4 (1), 141\u2013158 (2020).","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"1","key":"99845_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s40001-023-01490-z","volume":"28","author":"Y Jia","year":"2023","unstructured":"Jia, Y., Zou, K. & Zou, L. Research progress of metabolomics in cervical cancer. Eur. J. Med. Res. 28 (1), 586 (2023).","journal-title":"Eur. J. Med. Res."},{"issue":"4","key":"99845_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000513545","volume":"30","author":"H Ashrafian","year":"2021","unstructured":"Ashrafian, H. et al. Metabolomics: the stethoscope for the Twenty-First century. Med. Princ Pract. 30 (4), 301\u2013310 (2021).","journal-title":"Med. Princ Pract."},{"issue":"1","key":"99845_CR48","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41467-017-00369-y","volume":"8","author":"HWS Tan","year":"2017","unstructured":"Tan, H. W. S., Sim, A. Y. L. & Long, Y. C. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation. Nat. Commun. 8 (1), 338 (2017).","journal-title":"Nat. Commun."},{"issue":"11","key":"99845_CR49","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.3390\/ijms19113325","volume":"19","author":"L Stuani","year":"2018","unstructured":"Stuani, L. et al. Stable isotope labeling highlights enhanced fatty acid and lipid metabolism in human acute myeloid leukemia. Int. J. Mol. Sci. 19 (11), 3325 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"99845_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1039\/D0MO00067A","volume":"17","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. NMR-based plasma metabolomics of adult B-cell acute lymphoblastic leukemia. Mol. Omics. 17 (1), 153\u2013159 (2021).","journal-title":"Mol. Omics"},{"issue":"6","key":"99845_CR51","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbabio.2010.09.003","volume":"1807","author":"G Solaini","year":"2011","unstructured":"Solaini, G., Sgarbi, G. & Baracca, A. Oxidative phosphorylation in cancer cells. Biochim. Et Biophys. Acta (BBA)-Bioenerg. 1807 (6), 534\u2013542 (2011).","journal-title":"Biochim. Et Biophys. Acta (BBA)-Bioenerg."},{"issue":"8","key":"99845_CR52","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11864-023-01104-0","volume":"24","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Targeting glutamine metabolism as an attractive therapeutic strategy for acute myeloid leukemia. Curr. Treat. Options Oncol. 24 (8), 1021\u20131035 (2023).","journal-title":"Curr. Treat. Opt. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99845-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99845-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99845-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:50:52Z","timestamp":1757357452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99845-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99845-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28576"}}